1. Immunology/Inflammation Apoptosis MAPK/ERK Pathway Stem Cell/Wnt Cytoskeleton PI3K/Akt/mTOR
  2. PD-1/PD-L1 Apoptosis ERK JNK Cadherin p38 MAPK GSK-3 IFNAR Caspase Bcl-2 Family
  3. SF-9-2

SF-9-2 是一种 PD-L1/PD-1 结合抑制剂 (IC50 = 24.9 nM)。SF-9-2 抑制了 SK-N-SH 细胞的上皮间质转化、迁移、侵袭和增殖,还诱导其凋亡 (apoptosis) 和细胞周期停滞。SF-9-2 通过 MAPK 信号通路阻断 PD-L1 诱导的 SK-N-SH 细胞生长。SF-9-2 恢复 GSK-3β 活性,并通过泛素-蛋白酶体通路增强 PD-L1 降解。SF-9-2 抑制了 SK-N-SH NOG 小鼠模型中的肿瘤生长,且无明显毒性。SF-9-2 还可作为免疫检查点抑制剂,阻断 PD-L1 以恢复 T 细胞功能。SF-9-2 可用于神经母细胞瘤研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

SF-9-2

SF-9-2 Chemical Structure

CAS No. : 3053768-78-5

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

SF-9-2 is a PD-L1/PD-1 binding inhibitor (IC50 = 24.9 nM). SF-9-2 inhibits epithelial-mesenchymal transition, migration, invasion, and proliferation of SK-N-SH cells, and also induces apoptosis and cell cycle arrest. SF-9-2 blocks PD-L1-induced SK-N-SH cell growth through the MAPK signaling pathway. SF-9-2 restores GSK-3β activity and enhances PD-L1 degradation through the ubiquitin-proteasome pathway. SF-9-2 inhibits tumor growth in the SK-N-SH NOG mouse model without significant toxicity. SF-9-2 also acts as an immune checkpoint inhibitor, blocking PD-L1 to restore T cell function. SF-9-2 can be used in neuroblastoma research[1].

IC50 & Target[1]

GSK-3β

 

Caspase 3

 

体外研究
(In Vitro)

SF-9-2 (0.5-16 μM, 48 小时) 对 SK-N-SH (IC50 = 5.9 μM) 和 SK-N-AS 细胞 (IC50 = 8.67 μM) 表现出显著的抑制活性,但对 SH-SY5Y 和 SK-N-BE (2) 细胞的抑制作用较小,对正常细胞 MRC-5 (IC50 = 12.15 μM) 表现出较弱的细胞毒性作用[1]
SF-9-2 (1-6 μM, 24 小时) 可抑制 SK-N-SH 细胞增殖、迁移、侵袭和上皮-间质转化 (EMT),并诱导其发生线粒体依赖性细胞凋亡和细胞周期停滞[1]
SF-9-2 (2.5-8 μM, 24-48 小时) 可通过靶向 ERK 信号通路抑制 SK-N-SH 细胞中的 MAPK 通路并下调 PD-L1 水平[1]
SF-9-2 (2.5-5 μM, 24 小时) 诱导 SK-N-SH 细胞中 GSK-3β 介导的 PD-L1 内化和蛋白酶体降解[1]
SF-9-2 (2.25-200 nM) 在过表达 PD-1 和 Fc-PD-L1 蛋白的 293T 细胞中可降低荧光信号,有效阻断的 PD-1/PD-L1 免疫检查点[1]
SF-9-2 (1-16 μM, 48 小时) 可提高 PBMCs 中 IFN-γ 的分泌水平,在 1、2 和 4 μM 浓度下对 PBMCs 无明显毒性[1]
SF-9-2 (1-8 μM, 48 小时) 可表现出直接的肿瘤杀伤活性和 T 细胞介导的针对 SK-N-SH 细胞的细胞毒作用[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Migration Assay [1]

Cell Line: SK-N-SH cells
Concentration: 1 μM, 2 μM, 4 μM
Incubation Time: 24 h
Result: Inhibited the migration, reduced the number of cells passing through the chamber, with the migration rate in the 1, 2, 4 μM group was 73.3%, 43.0%, 13.4%, respectively.

Western Blot Analysis[1]

Cell Line: SK-N-SH cells
Concentration: 2.5 μM, 5 μM
Incubation Time: 24 h, 48 h
Result: Up-regulated the expressions of N-cadherin and E-cadherin, and down-regulated the expressions of β-catenin, and vimentin.
Reduced the Bcl-2/BAX ratio and increased the cleavage of Caspase 3.
Reduced the phosphorylation levels of ERK and JNK, and increased the phosphorylation level of p38 at 48 h.
Reduced PD-L1 levels at 5 μM.
Reduced the level of p-GSK-3β (Ser9), weakened the inhibitory effect of p-ERK on GSK-3β to a certain extent, and promoted the activation of GSK-3β at 5 μM.

Apoptosis Analysis[1]

Cell Line: SK-N-SH cells
Concentration: 1 μM, 3 μM, 6 μM
Incubation Time: 24 h
Result: Induced apoptosis, with the proportion of early and late apoptotic cells increasing in a dose-dependent manner.

Cell Cycle Analysis[1]

Cell Line: SK-N-SH cells
Concentration: 1 μM, 3 μM, 6 μM
Incubation Time: 24 h
Result: Increased the proportion of cells in the G1/S phase while decreasing the percentage of cells in the G2 phase.

Western Blot Analysis[1]

Cell Line: PD-L1 knockdown SK-N-SH cells
Concentration: 2.5 μM, 5 μM
Incubation Time: 24 h
Result: Was weaker than that in normal SK-N-SH cells for the downregulation of ERK phosphorylation.

Immunofluorescence[1]

Cell Line: SK-N-SH cells
Concentration: 2.5 μM
Incubation Time: 24 h
Result: Reduced PD-L1 on the cell surface (red fluorescence) and internalized it into the cytoplasm as compound concentration increases.

ELISA Assay[1]

Cell Line: PBMCs
Concentration: 1 μM, 2 μM, 4 μM
Incubation Time: 48 h
Result: Increased the secretion level of IFN-γ at 4 μM.
体内研究
(In Vivo)

SF-9-2 (20-40 mg/kg,腹腔注射,每天一次,21 天) 抑制 NOG 小鼠模型中的 SK-N-SH 肿瘤生长[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: SK-N-SH tumor (50 million cells/mL, s.c.) female NOG mice (5 weeks old, 17-20 g) model[1]
Dosage: 20 mg/kg, 40 mg/kg
Administration: i.p., once a day, 21 days
Result: Inhibited tumor growth, with tumor inhibition rates of 23.79% (20 mg/kg) and 69.45% (40 mg/kg) respectively.
Had no effects on body weight or mortality, exhibited no apparent nephrotoxicity or hepatotoxicity.
分子量

515.55

Formula

C30H27F2N3O3

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
SF-9-2
目录号:
HY-175236
需求量: